Acute Myocardial Infarction in a 26-Year-Old Patient With Familial Hypercholesteremia

Takeshi Miyayama1, Shin-Ichiro Miura2, Tomo Komaki3

  • 1Postgraduate Clinical Training Center, Fukuoka University Hospital, Fukuoka, Japan.

Insights

A young man experienced acute myocardial infarction due to blocked arteries. Early intervention and managing cholesterol, especially in familial hypercholesteremia, are crucial for recovery.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Acute myocardial infarction (AMI) in young adults is uncommon but serious.
  • Familial hypercholesteremia (FH) is a genetic disorder leading to high cholesterol and increased cardiovascular risk.

Observation:

  • A 26-year-old male presented with chest pain, ST-segment elevation, and elevated troponin-I, indicative of AMI.
  • Coronary angiography revealed significant stenosis in the right coronary artery and total occlusion of the left anterior descending artery (LAD).
  • The patient had multiple cardiovascular risk factors, including heterozygous FH, obesity, smoking, hypertension, and diabetes.

Findings:

  • Percutaneous coronary intervention (PCI) was performed on the LAD, restoring coronary blood flow (TIMI 3).
  • The case highlights a young patient with AMI and significant risk factors, particularly FH.
  • Prompt diagnosis and intervention are vital for managing acute cardiac events.

Implications:

  • This case underscores the importance of early diagnosis and aggressive management of cardiovascular risk factors, especially hypercholesterolemia, in young individuals.
  • Controlling cholesterol levels in patients with FH may prevent premature cardiovascular events like myocardial infarction.
  • Further research into the long-term outcomes and optimal management strategies for young patients with AMI and FH is warranted.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
398
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
640
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
653
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
915
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K